|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis显示文摘Peritonitis continues to be a major complication of peritoneal dialysis(PD), and adequate treatment is crucial for a favorable outcome. There is no consensus regarding the optimal therapeutic regimen, and few prospective controlled studies have been published. The objective of this manuscript is to review the results of PD peritonitis treatment reported in narrative reviews, systematic reviews, and proportional meta-analyses. Two narrative reviews, the only existing systematic review and its update published between 1991 and 2014 were included. In addition, we reported the results of a proportional metaanalysis published by our group. Results from systematic reviews of randomized control trials(RCT) and quasiRCT were not able to identify any optimal antimicrobial treatment, but glycopeptide regimens were more likely to achieve a complete cure than a first generation cephalosporin. Compared to urokinase, simultaneous catheter removal and replacement resulted in better outcomes. Continuous and intermittent IP antibiotic use had similar outcomes. Intraperitoneal antibiotics were superior to intravenous antibiotics in reducing treatment failure. In the proportional meta-analysis of RCTs and the case series, the resolution rate(86%) of ceftazidime plus glycopeptide as initial treatment was significantly higher than first generation cephalosporin plus aminoglycosides(66%) and glycopeptides plus aminoglycosides(75%). Other comparisons of regimens used for either initial treatment or treatment of gram-positive rods or gramnegative rods did not show statistically significant differences. The superiority of a combination of a glycopeptide and a third generation cephalosporin was also reported by a narrative review study published in 1991, which reported an 88% resolution rate. | Pasqual Barretti Joo Vitor Pereira Doles Douglas Gonalves Pinotti Regina Paolucci El Dib | 2015 | World Journal of Nephrology2015，4，2： | 9 |
| 2 | The epidemiology of on-albicans Candida in oropharyngeal candidiasis in HIV patients显示文摘 | Redding SW Kirkpatrick WR Dib O | 2000 | Spec Care Dentist2000，20，5： | 1 |
| 3 | 显示文摘 | Andrade A Z Rodrigues J K Dib L A Rom?o G S Ferriani R A Jord?o Junior A A | 2010 | Rev Bras Ginecol Obstet2010，32，： | 1 |
| 4 | Vasa vasorum imaging: A new window to the clinical detection of vulnerable atherosclerotic plaques显示文摘 | Stéphane Carlier MD PhD Ioannis A. Kakadiaris PhD Nabil Dib MD Manolis Vavuranakis MD Sean M. O’Malley BSc Khawar Gul MD Craig J. Hartley MD Ralph Metcalfe MD Roxana Mehran MD Christodoulos Stefanadis MD Erling Falk MD Gregg Stone MD Martin Leon MD Morte | 2005 | Current Atherosclerosis Reports2005，，2： | 1 |
| 5 | Efficacy of melphalan and predni- sone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01 /01 trial 显示文摘 | Hulin C Facon T Rodon P Pegourie B Benboubker L Doyen C Dib M Guillerm G SalIes B Esehard JP Lenain P Casas- sus P Azais I Decaux O Garderet L Mathiot C Fontan J Lafon I Virion JM Moreau P | 2009 | J Clin On- col2009，27，22： | 1 |
| 6 | The epidemiology of non -albieans Candida in ogrpharyngeal candidiasis in HIV patients 显示文摘 | Redding SW Kirkpatriek WR Dib O | 2000 | Spec Care Dentist2000，20，： | 1 |
| 7 | The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients显示文摘 | Redding S W Kirkpatrick W R Dib O | 2000 | Spec Care Dentist2000，20，5： | 1 |
| 8 | Category theoretic properties of topological structures and proximity structureson L-fuzzy space显示文摘 | Dib K A Tantawy O A Kamel G A | | Fuzzy Systems and Mathematics0，，： | 1 |
| 9 | The pro-inflammatory media-tor leukotriene D4 induces phosphatidylinositol 3-kinase andRac-dependentmigration of intestinal epithelial cells 显示文摘 | Paruchuri S Broom O Dib K | 2005 | J BiolChem2005，280，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员